Variable penetrance of schizophrenia in 22q11.2 deletion syndrome is associated with impaired, but reversible, neuronal mitophagy.
- 1Children's Hospital of Philadelphia
Abstract
The 22q11.2 deletion syndrome (22qDS) is a major genetic risk factor for schizophrenia (Sz). We found that iPSC-derived neurons (iNeurons) from 22qDS +Sz individuals exhibit weaker mitochondrial energetics, whereas iNeurons from individuals with the same deletion but no psychosis (22qDS -Sz) upregulate expression of mitochondrial biogenesis-related genes. Here, we investigated why the +Sz group fails to undergo this compensation, finding that 22qDS +Sz iNeurons have older and more depolarized mitochondria than 22qDS -Sz or controls. Transcriptomic and proteomic analyses revealed downregulation of mitophagy-related pathways, and live imaging revealed elevated lysosomal pH. Restoring lysosomal acidity with acidifying nanoparticles improved mitophagy and, remarkably, increased the expression of mitochondrial biogenesis-related transcription factors in the +Sz neurons. We conclude that lysosomal dysfunction and impaired mitophagy differentiate 22qDS individuals who develop schizophrenia from those who do not. Mitophagy could be a novel therapeutic or preventative opportunity for Sz in the context of genetic neurodevelopmental disorders.
Related
- Urolithin A Attenuates Noise-induced Hearing Loss and Is Associated With Increased Cochlear Mitophagy Markers
- CCR5, CD163, CSF1R, and FCGR3A as Candidate Biomarkers Associated With Mitophagy in Atherosclerosis.
- ABO Blood Group and von Willebrand Factor Levels Partially Explained the Incomplete Penetrance of Congenital Thrombophilia
- Case Report: Late postpartum eclampsia-associated reversible posterior encephalopathy syndrome with anti-DPPX encephalitis
- 2-bromopalmitate modulates macrophage polarization and mitophagy through STAT1-associated signaling in immune thrombocytopenia
BibTeX
@misc{stronati2026variable,
title = {{Variable penetrance of schizophrenia in 22q11.2 deletion syndrome is associated with impaired, but reversible, neuronal mitophagy.}},
author = {E. Stronati and A. J. Rossano and J. Li and A. R. Stoesser and D. C. Wallace and C. Giulivi and S. A. Anderson},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.13.766189},
url = {https://www.biorxiv.org/content/10.64898/2026.11.13.766189v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Variable penetrance of schizophrenia in 22q11.2 deletion syndrome is associated with impaired, but reversible, neuronal mitophagy.
AU - E. Stronati
AU - A. J. Rossano
AU - J. Li
AU - A. R. Stoesser
AU - D. C. Wallace
AU - C. Giulivi
AU - S. A. Anderson
PY - 2026
DA - 2026/11/13
PB - bioRxiv
DO - 10.64898/2026.11.13.766189
UR - https://www.biorxiv.org/content/10.64898/2026.11.13.766189v1
AB - The 22q11.2 deletion syndrome (22qDS) is a major genetic risk factor for schizophrenia (Sz). We found that iPSC-derived neurons (iNeurons) from 22qDS +Sz individuals exhibit weaker mitochondrial energetics, whereas iNeurons from individuals with the same deletion but no psychosis (22qDS -Sz) upregulate expression of mitochondrial biogenesis-related genes. Here, we investigated why the +Sz group fails to undergo this compensation, finding that 22qDS +Sz iNeurons have older and more depolarized mitochondria than 22qDS -Sz or controls. Transcriptomic and proteomic analyses revealed downregulation of mitophagy-related pathways, and live imaging revealed elevated lysosomal pH. Restoring lysosomal acidity with acidifying nanoparticles improved mitophagy and, remarkably, increased the expression of mitochondrial biogenesis-related transcription factors in the +Sz neurons. We conclude that lysosomal dysfunction and impaired mitophagy differentiate 22qDS individuals who develop schizophrenia from those who do not. Mitophagy could be a novel therapeutic or preventative opportunity for Sz in the context of genetic neurodevelopmental disorders.
ER -